Republican Lawmakers Condemn Biden Administration’s ‘Aggressive Campaign’ Against Early COVID Treatment
Senate Republicans, led by Sen. Ron Johnson (R-WI), joined with the House Freedom Caucus to accuse the Biden administration of participating “in an aggressive campaign against the use of specific early treatment options.”
Johnson and 21 of his Republican colleagues wrote October 5 to Health and Human Services Secretary Xavier Becerra, Chief White House Medical Advisor Dr. Anthony Fauci, Centers for Disease Control and Prevention Director Dr. Rochelle Walensky, and Acting Food and Drug Administration (FDA) Commissioner Dr. Janet Woodcock.
“Throughout the COVID-19 pandemic, public health officials have not only ignored potential early treatments, but at times seem to have participated in an aggressive campaign against the use of specific early treatment options,” the lawmakers began their letter.
They proceeded to accuse the Biden health officials of “overtly” discouraging “the use of cheap and widely-available early treatments like ivermectin in favor of expensive new drugs like Remdesivir (which costs more than $3,000 per treatment).”
“Despite the National Institutes of Health (NIH) funding a study examining the effectiveness of ivermectin as an early treatment for COVID-19, your agencies have already demonstrated your strong bias against this and other potential early treatment drugs,” the Republicans wrote, adding the FDA went as far as to jeer at the use of ivermectin, thereby “conflating a widely-available human drug that was the basis for Nobel prize winning research, with its veterinary version,” a move that “has cast doubt over the integrity of this study’s eventual results.”
“Physicians have utilized a variety of repurposed drugs and vitamins to treat COVID-19 since the early days of the pandemic,” the lawmakers observed. “As the list of potential drugs grows, we are concerned by your lack of urgency to explore, research, and recommend use of those drugs.”
In November 2020, Johnson, then chairman of the Senate Homeland Security and Governmental Affairs Committee, hosted the first of two hearings focused on early treatment of COVID-19. That hearing featured testimony by Drs. Peter McCullough, Harvey Risch, and George Fareed – all researchers and practitioners who have successfully treated patients who have had COVID.
In his opening statement, Johnson remarked on the obvious crux of the matter:
We are all aware that Tamiflu is only effective when prescribed early enough to stop the flu virus from replicating, and before the patient becomes too sick. Why haven’t federal agencies, and the medical community, applied the same logic and approach to coronavirus?
However, Sen. Gary Peters (D-MI), then ranking member of the Senate committee, continued the Democrats’ narrative, and accused the Trump administration of having “continued to exert pressure on our governments’ top public health agencies to water down health guidance and even promote unproven treatments, further putting Americans at risk.”
Peters said treatments that have not been recommended by the nation’s public health officials are not “rooted in science and transparency.”
“Unfortunately, misinformation and disinformation continue to run rampant,” the senator said.
Peters’ witness was Dr. Ashish K. Jha, who has appeared as a coronavirus expert on CNN, and admitted, upon questioning by Johnson, he has never even treated patients with the COVID infection.
Ahead of the hearing, Jha appeared to be mocking the topic, writing Johnson “wants to discuss Hydroxychloroquine as outpt therapy for COVID.”
“Other witnesses are all big Hydroxy fans so I’ll be a little lonely,” he added.
Jha said in his prepared testimony the “consensus in the scientific community, based on overwhelming evidence, is that hydroxychloroquine provides no benefits in treating COVID-19, and may produce significant harms.”
Nevertheless, Risch, professor of epidemiology at Yale University, testified that hydroxychloroquine (HCQ) is “exceedingly safe”:
Common sense tells us this, that a medication safely used for 65 years by hundreds of millions of people in tens of billions of doses worldwide, prescribed without routine screening EKGs, given to adults, children, pregnant women and nursing mothers, must be safe when used in the initial viral-replication phase of an illness that is similar at that point to colds or flu.
The Republican lawmakers continued in their letter to the Biden health officials:
Since these hearings, evidence of the potential of ivermectin and other repurposed drugs to treat COVID-19 has continued to accumulate. For example, Mexico City and India’s Uttar Pradesh have both reportedly experienced positive outcomes after using ivermectin to treat individuals with COVID-19. Mexico City apparently saw reduced hospitalizations and Uttar Pradesh experienced lower positivity and fatality rates.10 Unfortunately, there appears to be a complete lack of information or interest by U.S. public health agencies to examine what factors contributed to these apparent positive outcomes.
“Your agencies have also taken steps to curtail the use of potential early treatments,” the lawmakers added. “Even
though an estimated 12 to 38 percent of doctor-office prescriptions are off-label treatment drugs,
your actions have created a new industry standard that restricts doctors’ abilities to prescribe certain off-label treatments for COVID-19.”
By claiming randomized controlled trials (RCTs) are required before these repurposed drugs can be used to treat the virus in its early stages, the legislators wrote, “you have dramatically tipped the scales in favor of expensive
The lawmakers conclude:
It is beyond puzzling that the federal government continues to ignore foundational medical principles like early treatment or natural immunity, that federal agencies lack basic data regarding vaccine immunity and durability, and that agencies will highlight the relatively few adverse events for one treatment—ivermectin—but largely ignore hundreds of thousands of adverse events and over 15,000 deaths reported on VAERS for COVID-19 vaccines.
“As the number of breakthrough COVID-19 cases increase in the U.S. it is urgent that Americans have
access to early treatment options,” they assert.
In comments to the Daily Caller, Johnson also cited how Big Tech has been complicit in the “aggressive campaign” against early treatment of COVID.
“Our federal health agencies failed to robustly explore and research early treatment options and have not been transparent with the American people,” the senator said. “This combination of censorship and dereliction in developing early treatment has tragically resulted in an untold number of lost lives.”
This content is for educational and discussion purposes. Any treatment undertaken in terms of COVID (or any illness) should be discussed with a licensed medical professional.